This Study Aims to Evaluate the Validity of Family-led Recordings for General Movement Assessment (GMA) Compared to Provider-led Recording in Neonates Born Under 29weeks
NCT ID: NCT07141654
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2025-10-01
2028-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Applying Prechtl's Assessment of General Movements for Preterm Infants Through Telemedicine
NCT03742635
Effects of Medical Complexity Using GMA on Lurie Children's In- and Outpatients
NCT01659710
Study of Generalized Movements for Early Prediction of Cerebral Palsy
NCT00749008
GMA and Peri in Moderate-late Preterms
NCT04073836
Associations Between General Movements Assessments and Cognitive Development
NCT05217056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Parents can communicate in French or English
3. Intention to come for regular follow-up in the MCH Neonatal Clinic and/or Physical/Occupational therapy appointments
Exclusion Criteria
29 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jarred Garfinkle
Principal investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2026-11839
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.